DNM1L and Parkinson disease: It is also noteworthy, that inhibition of Drp-1 by Mdivi-1 possibly returned these effects of D1 receptor agonist in D1 antagonist treated PD rats, indicating the involvement of Drp-1 in D1 receptor mediated signaling [198].